MACH7 TECHNOLOGIES LIMITED — Capital/Financing Update 2025

Oct 30, 2025

ASX Announcement

31 October 2025

==> picture [104 x 26] intentionally omitted <==

VETERANS HEALTH ADMINISTRATION NATIONAL TELERADIOLOGY PROGRAM GOES LIVE

Mach7 Technologies Limited (“M7T” or “the Company”) (ASX:M7T), a company specialising in innovative medical imaging software solutions announces positive progress executing Phase 1 of its engagement with the Veterans Health Administration’s (VHA) National Teleradiology Program (NTP).

The NTP is the Veterans Affairs in-house teleradiology service which provides 24x7 services to 125 unique sites across all 18 Veterans Integrated Services Networks (VISNs).

As one of several subcontractors to the prime vendor, Frontier Acquisitions LLC, Mach7 is providing its Vendor Neutral Archive (VNA), eUnity Diagnostic Viewer and Professional Services as part of a best of breed Next Generation PACS[1] solution.

The Next Generation PACS program consists of two major phases. Under Phase 1, Mach7’s VNA and eUnity Viewer form the core of the NTP’s Next Generation PACS which is expected to interpret 1.01.5m studies annually. This phase has a potential Total Contract Value (TCV) of A$11.7M based on a fee per study subscription licence over a 3-year term.

Mach7 has completed initial milestones for a limited go-live in mammography and telestroke with a plan for a phased rollout for the remainder of Phase 1 through the month of November. A successful rollout of Phase 1 opens up the potential for a Phase 2 expansion into the VHA hospital network beyond the NTP.

Mach7 CEO and Managing Director Teri Thomas said: “The NTP go-live is a culmination of years of preparatory work in a highly secure environment. This go-live is an important milestone for Mach7 and testament to the hard work and dedication of a large multi-company team. The solution supports swift and accurate diagnoses regardless of physical location for our veterans. Mach7’s inclusion in the project demonstrates its strengths in interoperability, cloud computing and seamless AI application integration.”

Released on authority of the Board by Teri Thomas, Managing Director and Chief Executive Officer.

For more information, contact:

Investor Relations

Françoise Dixon +61 (0) 412 292 977 ir@mach7t.com

1 Picture Archiving and Communication System.

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Suite 2, Level 11, 385 Bourke St, Melbourne, VIC 3000 T: 03 9692 7222 www.mach7t.com

==> picture [104 x 26] intentionally omitted <==

ASX Announcement

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) is a leading provider of medical imaging software, delivering advanced data management and diagnostic viewing solutions to healthcare organisations worldwide. The Mach7 Enterprise Imaging Solution (EIS) is a next-generation solution combining a powerful Vendor Neutral Archive (VNA), the eUnity Enterprise Diagnostic Viewer, and robust diagnostic workflow applications. Built for maximum flexibility and scalability, Mach7 empowers customers to implement a complete enterprise imaging ecosystem or deploy modular components that fit their unique needs. Today, Mach7 supports a diverse global network, from large integrated delivery networks (IDNs) and national health systems to independent provider groups and private radiology practices. Visit Mach7t.com for more information.

Forward-looking statements

This announcement may contain forward-looking statements regarding the Company’s financial position, business strategy and objectives (rather than being based on historical or current facts). Any forward-looking statements are based on the current beliefs of the Company’s management as well as assumptions made by, and information currently available to, the Company’s management. Forward-looking statements are inherently uncertain and must be read accordingly. There can be no assurance that some or all of the underlying assumptions will prove to be valid.

All data presented in this announcement reflects the current views of the Company with respect to future events. Forward-looking statements are subject to risk, uncertainties and assumptions relating to the operations, results of operations, growth strategy and liquidity of the Company. To the maximum extent permitted by law, the Company, its officers, employees and agents do not accept any obligation to release any updates or revisions to the information (including any forward-looking statements) in this announcement to reflect any change to expectations or assumptions; and disclaim all responsibility and liability for any loss arising from reliance on this announcement or its contents.

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Suite 2, Level 11, 385 Bourke St, Melbourne, VIC 3000 T: 03 9692 7222 www.mach7t.com